Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Ausberto B. Hidalgo, M.D.
EIR
•Ausberto B. Hidalgo, M.D.•December 3, 2021

Ausberto B. Hidalgo, M.D. – FDA EIR, Dec 3, 2021

Record Details

An FDA inspection of Clinical Investigator Ausberto B. Hidalgo, M.D., operating with Luminous Clinical Research in Pembroke Pines, FL, was conducted from November 29 to December 3, 2021. This pre-announced, comprehensive surveillance inspection, requested by CDER, focused on Protocol GS-US-540-9012, a Phase 3 COVID-19 treatment trial sponsored by Gilead Sciences, Inc. The inspection identified two primary objectionable conditions, resulting in an FDA Form 483. First, Dr. Hidalgo's site failed to conduct the study in accordance with the investigational plan, including missing required COVID-19 test results for multiple subjects and enrolling several subjects who did not meet the protocol's eligibility criteria, with one instance involving an unsupported change to a subject's symptom start date. Second, the site failed to report these significant study protocol deviations to the Institutional Review Board (IRB) prior to their implementation. These violations relate to federal regulations concerning the conduct of investigational studies and the requirement for IRB approval of changes in research activity. Dr. Hidalgo verbally acknowledged the findings and committed to implementing several corrective actions, including developing quality control procedures for laboratory assessments, retraining staff on data integrity principles, establishing a standard operating procedure for data corrections, and ensuring timely shipping of laboratory samples. Additionally, the site committed to improving documentation for COVID-19 testing, including lot numbers, dates, times, and signatures, and establishing training and SOPs for testing quality.

Company
Ausberto B. Hidalgo, M.D.
Inspection date
December 3, 2021
Product type
drugs
Office
Florida District Office
Person
  • Latrice G. Jones (issuing_officer)
View Company Profile

ID · 21960dac-b54a-428e-8463-202c1e13f898

Violation Codes3
21 CFR 312.6021 CFR 312.6621 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Ausberto B. Hidalgo, M.D.
  • 483 - 2021-12-03December 3, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ausberto B. Hidalgo, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.